Slide 1DAMAGE CONTROL IN THE PATIENT IN SHOCK: MEDICAL AND SURGICAL THERAPIES ANA NAVÍO M.D. Ph.D. EMERGENCY DEPARTMENT, LA PAZ UNIVERSITY HOSPITAL, MADRID, SPAIN Slide…
1. MS variability and prognostic implications Laboratory Gavin Giovannoni Barts and The London School of Medicine and Dentistry 2. Disclosures Professor Giovannoni has received…
1. L1: MS diagnosisMcDonald’s criteriaGavin GiovannoniInstitute of Cell and Molecular ScienceBarts and The London School of Medicine and Dentistry 2. thWhat is multiple…
1. Update in body fluid markers Gavin GiovannoniBarts and The London School of Medicine and Dentistry 2. Why MS biomarkers?• Diagnostic testing– Positive & negative…
1. Copyright 2012 by ESPGHAN and NASPGHAN. Unauthorized reproduction of this article is prohibited. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition…
Slide 1Ethics in Alzheimer's Disease: New diagnostic criteria, new biomarkers, new challenges Steven T. DeKosky, MD James Carroll Flippin Professor of Medical Science…